Dow Chemical ’s Silicone Business Play: What It Means for Medtech
Dow Chemical as of mid-2016 became 100% owner of Dow Corning’s silicones business.
The move created both an opportunity and challenge because it represents a marriage of organic chemistry and inorganic chemistry. How can the two complement each other and drive innovation? And how will the deal affect the medical device industry?
The move created both an opportunity and challenge because it represents a marriage of organic chemistry and inorganic chemistry. How can the two complement each other and drive innovation? And how will the deal affect the medical device industry?